Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- The patient must be female and under 18 years old.
- The patient must have breast cancer that has been confirmed through a tissue sample analysis.
- The patient's breast cancer must be HER-2 negative, meaning it can be either hormone receptor-positive or triple-negative (confirm with trial site if unsure which type applies).
- The patient must be planned to receive chemotherapy or other treatment before surgery (known as neo-adjuvant therapy).
- Complete medical, imaging, and treatment records must be available for the patient.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Patients whose breast cancer has spread to other parts of the body (metastatic breast cancer) are not eligible.
- Patients whose breast cancer is HER-2 positive are not eligible.
- Patients with incomplete medical, imaging, or treatment records are not eligible.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: summar mohamed summar el-morshidy, lecturer, Assiut University
Phone: +201020597669
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
: assess prognostic significance of TREM-1 expression at baseline and post neo-adjuvant treatment regards DFS & OS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.